Weigao Group buys back 0.13 million H-shares on 24 June, lifting treasury stock to 59.96 million

Bulletin Express06-24

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed a repurchase of 130,000 H-shares on 24 June 2026 via on-exchange transactions.

The shares were bought at prices ranging between HKD 3.13 and HKD 3.18, with a volume-weighted average of HKD 3.1538. Total consideration reached approximately HKD 0.41 million.

After the transaction: • Issued shares (excluding treasury shares) declined to 4.46 billion, down by 0.0029%. • Treasury shares increased to 59.96 million, keeping total issued shares unchanged at 4.52 billion.

The buy-back forms part of the mandate approved on 29 May 2026, which authorises repurchases of up to 446.46 million shares. To date, Weigao Group has repurchased 2.64 million shares, representing 0.591% of the company’s issued share capital at the mandate date.

Under Hong Kong listing rules, Weigao Group is restricted from issuing new shares or disposing of treasury shares until 24 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment